January 10, 2023

To,

Listing Department,

National Stock Exchange of India Limited

Exchange Plaza, Plot No C-1, Block G, Bandra Kurla Complex,

Bandra (E), Mumbai - 400051

NSE Symbol: BALAXI

Subject: Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the period ended December 31, 2022.

Dear Sir/Madam,

In terms of the provisions of Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we enclose herewith copy of the certificate received from Aarthi Consultants Private Limited, the Registrar and Share Transfer Agent of the Company for the period ended December 31, 2022.

This is for your information and records.

Yours Faithfully,

For Balaxi Pharmaceuticals Limited

Digitally signed

Udayan by Udayan

Shukla

Shukla Date: 2023.01.10 12:08:06 +05'30'

Udayan Shukla

(Company Secretary & Compliance Officer)

Membership No.: F11744

Encl: As above

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Balaxi Pharmaceuticals Ltd. published this content on 10 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 January 2023 07:16:12 UTC.